Advisor Group’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$19K Buy
1,202
+25
+2% +$359 ﹤0.01% 4001
2019
Q3
$17K Hold
1,177
﹤0.01% 4071
2019
Q2
$22K Sell
1,177
-357
-23% -$8.09K ﹤0.01% 3939
2019
Q1
$54K Buy
1,534
+805
+110% +$31.8K ﹤0.01% 3335
2018
Q4
$29K Buy
729
+28
+4% +$1.71K ﹤0.01% 3560
2018
Q3
$60K Buy
701
+104
+17% +$10.3K ﹤0.01% 3149
2018
Q2
$49K Buy
597
+364
+156% +$22.3K ﹤0.01% 3127
2018
Q1
$8K Sell
233
-225
-49% -$8.72K ﹤0.01% 4222
2017
Q4
$17K Buy
458
+208
+83% +$9.39K ﹤0.01% 3810
2017
Q3
$14K Buy
+250
New +$11.8K ﹤0.01% 3785

Other funds holding VSTM

Advisor Group's VSTM Position: Q4 2019 in Review

Advisor Group increased its Verastem (VSTM) stake by 2.1% in Q4 2019, buying an estimated $359 and bringing the position to 1,202 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #4001.

Advisor Group first reported a position in VSTM in Q3 2017 and has held it in 10 quarters since. The position peaked at $60K in Q3 2018. 82 funds tracked by Wall St. Rank hold VSTM as of Q4 2019.

  • Advisor Group held 1,202 shares of Verastem worth $19K as of Q4 2019.
  • Advisor Group bought 25 Verastem shares in Q4 2019, an estimated $359.
  • Verastem made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4001 holding.
  • Advisor Group first reported a position in Verastem in Q3 2017 and has held it in 10 quarters since.
  • Advisor Group's Verastem position peaked at $60K in Q3 2018.
  • 82 funds tracked by Wall St. Rank held Verastem as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.